The valuation for is looking very attractive. The company trades at a discount on all measures except book value. The trailing 12 month PE multiple of 20x is below the 23x industry average. The forward earnings multiple of 16x looks almost cheap compared to the 21x industry average. The stock trades at 6.8x book value and the is the lone metric that has the stock trading a premium to the industry average of 4.5x. Price to sales of 1.3x is well below 3.5x industry average.